Nanalysis Scientific Corp. (TSXV:NSCI)

Market Cap	26.78M
Revenue (ttm)	44.93M
Net Income (ttm)	-12.40M
Shares Out	116.42M
EPS (ttm)	-0.11
PE Ratio	n/a
Forward PE	29.95
Dividend	n/a
Ex-Dividend Date	n/a

Volume	31,013
Average Volume	193,824
Open	0.2450
Previous Close	0.2300
Day's Range	0.2450 - 0.2450
52-Week Range	0.2300 - 0.4600
Beta	0.30
RSI	50.74
Earnings Date	Aug 22, 2025

About Nanalysis Scientific

Nanalysis Scientific Corp. develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Europe, Asia, and internationally. The company operates through Scientific Equipment and Security Services segment. It offers nuclear magnetic resonance (NMR) spectrometers; magnetic resonance test, and measurement and diagnostic system; 60-NMR platform; 100-NMR platform; 60-TEACH Platform; QUAD NMR Console; and Cameleon 4 console, a compact alternative to facilitate MRI for teaching. The company also provides softwa...

• Industry: Scientific & Technical Instruments
• Sector: Technology
• CEO: Sean Krakiwsky
• Employees: 249
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: NSCI

Financial Performance

In 2024, Nanalysis Scientific's revenue was 45.50 million, an increase of 59.82% compared to the previous year's 28.47 million. Losses were -13.61 million, -15.95% less than in 2023.